Veracyte | VCYT - Ebitda

Stock Price
33.29
Daily Change
-0.19 -0.57%
Monthly
-8.24%
Yearly
4.75%
Q1 Forecast
31.16

Veracyte reported $42.31M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Agenus USD -10.11M 19.02M Mar/2025
Agilent USD 540M 74M Sep/2025
Anika Therapeutics USD -2.69M 4.73M Mar/2025
Arrowhead Research USD 64.2M 223.53M Sep/2025
Bruker USD 211.6M 207.4M Dec/2025
Exact Sciences USD 135.42M 2.8M Sep/2025
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Illumina USD 332M 12M Sep/2025
Intrexon USD -24.7M 2.92M Jun/2024
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Laboratory Of America USD 588.1M 24.1M Dec/2025
Ligand Pharmaceuticals USD 150.32M 129.42M Sep/2025
Myriad Genetics USD 10.3M 4.2M Sep/2025
Rigel Pharmaceuticals USD -4.17M 798K Sep/2023
Roche Holding CHF 12.68B 2.36B Jun/2024
Siemens EUR 3.64B 535M Dec/2025
Sonic Healthcare AUD 839.07M 51.09M Dec/2024
Thermo Fisher Scientific USD 3.17B 335M Dec/2025
Veracyte USD 42.31M 2.58M Dec/2025
Waters USD 380.97M 85.83M Dec/2025